Nanooptogenetic immunotherapy for B cell lymphoma

Ended Project Grant Awarded Last action

Award ID
R01CA232017
Recipient
Awarding agency
Obligated
$2,186,934

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
Worcester, MA 01605, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $407,858
Amendment $418,557
Amendment $437,693
Amendment $447,986
Original award $474,840

Subawards

Subrecipient Amount Awarded
Texas A & M University System Health Science Center Research The goal of this multidisciplinary and transformative project aims to combine innovative nanotechnology, optogenetics with immunoengineering to develop next… $192,762

Quick answers

Who received award R01CA232017?

R01CA232017 was awarded to University Of Massachusetts Medical School by National Cancer Institute (National Institutes of Health) on March 4, 2019.

How much is award R01CA232017 worth?

$2,186,934 has been obligated on R01CA232017.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award